344 related articles for article (PubMed ID: 29562730)
1. Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo.
Hwang YH; Kim KJ; Kim SJ; Mun SK; Hong SG; Son YJ; Yee ST
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562730
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibitory effect of Foeniculum vulgare Miller extract on osteoclast differentiation and ovariectomy-induced bone loss.
Kim TH; Kim HJ; Lee SH; Kim SY
Int J Mol Med; 2012 Jun; 29(6):1053-9. PubMed ID: 22447109
[TBL] [Abstract][Full Text] [Related]
3. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin-3-gallate inhibits RANKL-induced osteoclastogenesis via downregulation of NFATc1 and suppression of HO-1-HMGB1-RAGE pathway.
Nishioku T; Kubo T; Kamada T; Okamoto K; Tsukuba T; Uto T; Shoyama Y
Biomed Res; 2020; 41(6):269-277. PubMed ID: 33268671
[TBL] [Abstract][Full Text] [Related]
5. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
[TBL] [Abstract][Full Text] [Related]
6. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
[TBL] [Abstract][Full Text] [Related]
7. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
[TBL] [Abstract][Full Text] [Related]
8. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X
Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
10.
Han SY; Kim JH; Jo EH; Kim YK
Molecules; 2021 Mar; 26(7):. PubMed ID: 33810474
[TBL] [Abstract][Full Text] [Related]
11. Turbo methanol extract inhibits bone resorption through regulation of T cell function.
Balakrishnan B; Indap MM; Singh SP; Krishna CM; Chiplunkar SV
Bone; 2014 Jan; 58():114-25. PubMed ID: 24140785
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
13. Effects of
Kim M; Kim JH; Hong S; Kwon B; Kim EY; Jung HS; Sohn Y
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184080
[TBL] [Abstract][Full Text] [Related]
14. Austalide K from the Fungus
Kim KJ; Lee J; Wang W; Lee Y; Oh E; Park KH; Park C; Woo GE; Son YJ; Kang H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071042
[TBL] [Abstract][Full Text] [Related]
15. Effect of oviductus ranae and oviductus ranae eggs on bone metabolism and osteoporosis.
Wang DH; Wu W; Tian JM; Wang ZH; Wang DT; Xiang K; Zhu GY; Han T
Chin J Integr Med; 2013 Jul; 19(7):532-8. PubMed ID: 23263999
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis.
Huang Q; Gao B; Jie Q; Wei BY; Fan J; Zhang HY; Zhang JK; Li XJ; Shi J; Luo ZJ; Yang L; Liu J
Bone; 2014 Sep; 66():306-14. PubMed ID: 24933344
[TBL] [Abstract][Full Text] [Related]
17. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
18. PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption.
Cho E; Chen Z; Lee J; Lee S; Lee TH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540026
[TBL] [Abstract][Full Text] [Related]
19. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
Hsiao HB; Lin H; Wu JB; Lin WC
Osteoporos Int; 2013 May; 24(5):1663-76. PubMed ID: 23143538
[TBL] [Abstract][Full Text] [Related]
20. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
